CD8A and pancreatic neoplasm: This correlated with an increase in immune function as observed on splenocytes from API treated pancreatic tumor-bearing (TB-API) mice exemplified by increase in the in vivo production of INF-γ CD8+ T cells in vivo and by robust allogeneic CD8+ T cell responses, in vitro.